FDA inspection
Haimen Pharma Co., Ltd.: FDA inspection ending Jan 10, 2020
FDA inspection 1115958 · No Action Indicated (NAI) · Nantong
Key facts
| Inspection ID | 1115958 |
|---|---|
| Firm | Haimen Pharma Co., Ltd. |
| FEI number | 3011266110 |
| Address | No. 163 Zhuhai Rd, Binjiang Street |
| City | Nantong |
| Country | China |
| Fiscal year | 2020 |
| Inspection end date | Jan 10, 2020 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data